Pharmacist involvement in sepsis response and time to antibiotics: A systematic review

被引:3
|
作者
Atkins, Payton E. [1 ]
Bastin, Melissa L. Thompson [1 ,2 ]
Morgan, Rebecca J. [3 ]
Laine, Melanie E. [1 ,2 ]
Flannery, Alexander H. [1 ,2 ]
机构
[1] Univ Kentucky, Dept Pharm Practice & Sci, Coll Pharm, 789 S Limestone St,TODD 251, Lexington, KY 40536 USA
[2] Univ Kentucky HealthCare, Dept Pharm Serv, Lexington, KY USA
[3] Univ Kentucky Lib, Med Ctr Lib, Lexington, KY USA
来源
JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY | 2023年 / 6卷 / 08期
基金
美国国家卫生研究院;
关键词
antibiotic; pharmacist; sepsis; septic shock; systematic review; ANTIMICROBIAL THERAPY; EMERGENCY-DEPARTMENT; SEPTIC SHOCK; IMPACT; MORTALITY; MULTICENTER; CANDIDEMIA;
D O I
10.1002/jac5.1723
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction Sepsis is a life-threatening medical emergency and a leading cause of morbidity and mortality worldwide. Reductions in time to antibiotics in patients presenting with sepsis or septic shock are associated with reduced mortality, and Surviving Sepsis Campaign guidelines recommend antibiotics within 1 h of recognition. Pharmacists are well-equipped to help navigate the therapeutic and operational challenges associated with achieving this goal. Objectives To assess the association of pharmacist involvement in sepsis response with time to antibiotics in hospitalized patients with sepsis and septic shock. Methods A systematic review of the following databases was conducted: PubMed/MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Web of Science. Studies must have included a designated role of an individual pharmacist in the management of sepsis or septic shock and not be considered an operational change. The primary outcome of interest was time to antibiotic administration, with secondary outcomes including intensive care unit (ICU) and hospital length of stay as well as in-hospital mortality. Results We identified 10 studies including 1772 patients with sepsis or septic shock that evaluated a sepsis response in which a pharmacist was included. Studies included patients in the ICU, emergency department, and hospital ward setting. Seven studies demonstrated a significant reduction in time to antibiotics, with two other studies supporting this conclusion in extrapolation or sensitivity analysis. There was not a consistent reduction in ICU or hospital length of stay nor in-hospital mortality between those interventions involving a pharmacist compared with their defined control groups. Conclusion Pharmacist involvement in sepsis response, often as part of a multiprofessional team-based approach to sepsis care, is associated with a reduced time to antibiotic administration for hospitalized patients with sepsis or septic shock.
引用
收藏
页码:942 / 953
页数:12
相关论文
共 50 条
  • [21] Patient and pharmacist perspectives on pharmacist-prescribed contraception: A systematic review
    Eckhaus, L. M.
    Ti, A. J.
    Curtis, K. M.
    Stewart-Lynch, A. L.
    Whiteman, M. K.
    CONTRACEPTION, 2021, 103 (02) : 66 - 74
  • [22] The impact of pharmacist involvement on immunization uptake and other outcomes: An updated systematic review and meta-analysis
    Le, Lan My
    Veettil, Sajesh K.
    Donaldson, Daniel
    Kategeaw, Warittakorn
    Hutubessy, Raymond
    Lambach, Philipp
    Chaiyakunapruk, Nathorn
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2022, 62 (05) : 1499 - +
  • [23] A systematic literature review and meta-analysis of community pharmacist-led interventions to optimise the use of antibiotics
    Lambert, Maarten
    Smit, Chloe C. H.
    De Vos, Stijn
    Benko, Ria
    Llor, Carl
    Paget, W. John
    Briant, Kathryn
    Pont, Lisa
    Van Dijk, Liset
    Taxis, Katja
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (06) : 2617 - 2641
  • [24] Effect of an emergency department sepsis protocol on time to antibiotics in severe sepsis
    Francis, Marc
    Rich, Tom
    Williamson, Tyler
    Peterson, Daniel
    CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2010, 12 (04) : 303 - 310
  • [25] Antibiotics and mania: A systematic review
    Lambrichts, Simon
    Van Oudenhove, Lukas
    Sienaert, Pascal
    JOURNAL OF AFFECTIVE DISORDERS, 2017, 219 : 149 - 156
  • [26] PHARMACIST INVOLVEMENT IN INSTITUTIONAL REVIEW OF CLINICAL-TRIALS
    RAEHL, CL
    MILLER, DE
    FOSTER, TS
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (03): : 334 - 339
  • [27] Prostacyclin in sepsis: A systematic review
    Zardi, E. M.
    Zardi, D. M.
    Dobrina, A.
    Afeltra, A.
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2007, 83 (1-2) : 1 - 24
  • [28] Biomarkers in sepsis: a systematic review
    F Morriello
    J Marshall
    Critical Care, 19 (Suppl 1):
  • [29] Pharmacist impact on time to antibiotic administration in patients with sepsis in an ED
    Moussavi, Kayvan
    Nikitenko, Vitaliy
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (11): : 2117 - 2121
  • [30] Pharmacist interventions in osteoporosis management: a systematic review
    Catherine Laird
    Helen Benson
    Kylie A. Williams
    Osteoporosis International, 2023, 34 : 239 - 254